We describe a procedure for the direct measurement of metanephrine (MN) and normetanephrine (NMN) in hydrolyzed urine, using HPLC with coulometric array detection. Acid-hydrolyzed samples were diluted and filtered before separation by isocratic reversed-phase ion-pair chromatography. Eight serial coulometric sensors, set at incrementally increasing anodic potentials, were used to screen lower-oxidizing interferences and provide stepwise oxidation of the metanephrines. Voltammetric behavior across three adjacent sensors was used to assess resolution and aid in peak identification.Values obtained in commercial controls were consistently within the specified target range. Variability, expressed as CV, was 5.45-9.22% between runs and 1.60-4.52% within-run for both compounds. The limit of detection was 2.6 g/L for MN and 2.8 gIL for NMN, with a linear response to 15.0 mgIL for both analytes. Results from patients' samples correlated well with those by a method invoMng dual ionexchange extraction (r = 0.963, n = 82 for MN; r = 0.9768, n = 83 for NMN). This procedure provided high selectivity and objective peak purity information while greatly simplifying sample preparation. Our objectives have been to: (a) decrease the sample handling required and (b) increase the qualitative data obtained in the determination of the urinary metanephrines. We used coulometric array detection (10) to increase resolution and provide voltammetric characterization of these analytes.
Because urine presents a very complex and variable matrix, solid and (or) liquid-phase extraction steps are normally required for purification before HPLC-ECD analysis.
Endogenous and dietary phenolic, aromatic amine, and heterocycic compounds may be oxidized at potentials similar to those used to detect the metanephrifles and can therefore interfere with their measurement (3). Likewise, drugs or drug metabolites, including many antihypertensiveagents, are often electroactive and must be removed by extraction before the analysis (6) (7) (8) (9) We examined the limits of detection, linearity, precision, and selectivity of this assay and compared our results with those by an HPLC method based on an off-line dual-column extraction procedure (11) in 85 samples from hypertensive patients. The total time for each analysis was 17 mm.
MaterIals and Methods

Apparatus.
HPLC-ECD analysis was performed with
Peak identification and single-point quantification were performed by comparison with the results for a Bio-Rad external standard run on the same day. Standards and controls were included with every 15 samples. The calculations were performed automatically with the CEAS software as fellows: Sample or control peaks were identified as MN or NMN if the dominant electrode (the sensor having the greatest response for each analyte) matched that of the external standard and the retention time (RT) was within ±2% of that of the external standard. If more than one peak satisfied these criteria, the response proffles across sensors 5, 6, and 7 (T5, T6, T7) were compared and the one giving the closest match with the standard was chosen. The response profile was measured as the peak-height ratios between these three sensors. Quantification was performed by using either the sum of the peak heights across T5, T6, and T7 when the response ratios were within ± 20%; otherwise, the response of only the dominant sensor was used.
Method comparison. The method comparison evaluation was performed at a clinical laboratory in which urinary metanephrines were routinely determined by using a Bio-Rad dual-column off-line extraction method prior to ion-exchange HPLC-ECD analysis (12). Over a period of 6 weeks, patients' samples were chosen to represent a range of low and high concentrations of both analytes, as determined by the existing routine method. Typically, 10 of these selected samples were analyzed along with standards, controls, and other experimental samples in each run of the CEAS method. Individual samples were analyzed within 5 days by both methods to avoid potential differences attributable to sample stability. We used several preparations of mobile phase and reagent batches as well as a change in standard and control batches over the course of this study to examine these possible sources of variabifity.
Results and DIscussion
The chromatographic conditions were chosen to allow selectivity on the basis of the ionic and hydrophobic characteristics of the metanephrines, with consideration of possible endogenous and exogenous interferences. At pH 5.3, amine compounds are highly protonated, whereas strongly and weakly acidic compounds retain their anionic nature. Under these conditions, a moderately strong hydrophobic eluent combined with a highly concentrated/long-carbon-chain countenion (SDS) provides selective retention of amine and very hydrophobic nonionic compounds on a reversed-phase column. The organic modifier and SDS concentration were determined experimentally by examining urine controls and pooled urine samples over a range of mobile phase conditions. The stationary phase was chosen on the basis of its history of providing greater peak symmetry than other silica-based this allowed efficient coulometric screening of lower-oxidizing interferences (e.g., dopamine, hydroxyindoles, and other catechols). The potentials of detectors 5, 6, 7, and 8 (T5-T8) were chosen such that 15% ± 5%, 65% ± 10%, 15% ± 5%, and 5% ± 3% of the total peak height (current) was obtained at each detector, respectively.
To obtain these proportions, we had to optimize the potentials of different detector arrays by typically ±20 mV. The metanephrines were measured primarily at T6 (dominant sensor); T5 (leadingsensor)and T7 (following sensor) were used for peak-ratio comparisons. Detector 8, being the most susceptible to higher-oxidizing interferences (e.g., phenols), was not used for quantification. ratios obtained from aqueous standards, normal controls, abnormal controls, and those patients' samples analyzed on the same day were consistently within 5% of the urine standard values. The intrarun variability in response ratios, expressed as CV, for 25 replicate injections of an abnormal control was 4.82% for T6/T5 and 2.89% for T6/T7. Because the response ratios varied by >5% between runs, quantification with standards run on the same day was necessary. Strict control of detector temperature, mobile phase composition, and electrode "cleaning" was used to minimize response ratio variability. Table 1 shows the percent response ratio "conformities" [(sample response ratio/standard response ratio) x 100] obtained from a representative run of 12 patients' samples and two sets of normal and abnormal controls. The response ratios provided an objective index for examining peak purity in all samples. The closer the conformity value to 100%, the greater the similarity in voltammetric behavior between sample peak and standard. A low value is a good and immediate indicator that an apparently pure chromatographic peak may comprise two or more solutes.
Linearity, limit of detection, and analytical recovery.
Assay linearity and limit of detection were examined by analyzing aqueous standards Table 2 ). The percentage recovery ± SD of added analyte was 96.0% ± 4.4% for MN (n = 42) and 97.4% ± 5.2% for NMN (n = 42) with no significant differences in recovery between higher and lower levels.
Precision. To examine the within-run variability of this assay, 10 replicates of a standard, a normal control, and an abnormal control were analyzed on each of three separate days. The average variation (CV) within-run for these 3 days were all <5% (Table 3) . Variability between runs was studied by analyzing two or more replicate standards, normal controls, and abnormal controls on 16 separate days. The average concentrations and variability data are presented in Table 3 . The controls were consistently within the target range specified by the manufacturer. Bio-Rad In these cases, no interferences were apparent with either method. Thirtyeight known endogenous metabolites, including possible "amine-like" compounds from the tyrosine, tryptophan, and purine metabolic pathways, were also tested. Dopamine and synephrine were the only oxidizable compounds that eluted within ±2 mm of the retention times of the metanephrines under these conditions. Dopamine eluted 1.5 min after MN, and synephrine eluted 0.5 mm before NMN. The voltammetric selectivity of the array allowed resolution of these compounds at >1000-fold higher concentrations.
Tyraniine and octopamine did not interfere with either NMN or MN.
In conclusion, the use of coulometric array detection with HPLC 
